Keeley Teton Advisors LLC Sells 1,065 Shares of Cabot Co. (NYSE:CBT)

Keeley Teton Advisors LLC lessened its stake in shares of Cabot Co. (NYSE:CBT) by 5.6% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 18,059 shares of the specialty chemicals company’s stock after selling 1,065 shares during the period. Keeley Teton Advisors LLC’s holdings in Cabot were worth $1,508,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. EverSource Wealth Advisors LLC grew its holdings in Cabot by 143.1% during the fourth quarter. EverSource Wealth Advisors LLC now owns 333 shares of the specialty chemicals company’s stock valued at $28,000 after purchasing an additional 196 shares during the period. Arlington Trust Co LLC purchased a new position in shares of Cabot in the fourth quarter valued at about $34,000. Hexagon Capital Partners LLC lifted its position in shares of Cabot by 81.8% in the fourth quarter. Hexagon Capital Partners LLC now owns 460 shares of the specialty chemicals company’s stock valued at $38,000 after acquiring an additional 207 shares in the last quarter. SRS Capital Advisors Inc. lifted its position in shares of Cabot by 372.0% in the fourth quarter. SRS Capital Advisors Inc. now owns 505 shares of the specialty chemicals company’s stock valued at $42,000 after acquiring an additional 398 shares in the last quarter. Finally, GAMMA Investing LLC purchased a new position in shares of Cabot in the fourth quarter valued at about $44,000. Institutional investors own 93.18% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the company. Deutsche Bank Aktiengesellschaft downgraded Cabot from a “buy” rating to a “hold” rating and boosted their price objective for the company from $88.00 to $95.00 in a research report on Thursday, April 18th. Mizuho boosted their price objective on Cabot from $104.00 to $109.00 and gave the company a “buy” rating in a research report on Tuesday, May 7th. StockNews.com upgraded Cabot from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, May 8th. Finally, UBS Group boosted their price objective on Cabot from $100.00 to $103.00 and gave the company a “neutral” rating in a research report on Tuesday, May 7th. Three research analysts have rated the stock with a hold rating, two have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $93.67.

Insider Buying and Selling at Cabot

In other Cabot news, SVP Karen A. Kalita sold 13,764 shares of the company’s stock in a transaction that occurred on Friday, May 10th. The stock was sold at an average price of $101.73, for a total transaction of $1,400,211.72. Following the sale, the senior vice president now directly owns 34,312 shares in the company, valued at $3,490,559.76. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 3.07% of the company’s stock.

Cabot Price Performance

Shares of NYSE:CBT traded down $0.41 during mid-day trading on Wednesday, reaching $98.38. The stock had a trading volume of 255,780 shares, compared to its average volume of 303,840. The company has a current ratio of 2.24, a quick ratio of 1.47 and a debt-to-equity ratio of 0.72. The company has a market cap of $5.44 billion, a P/E ratio of 12.46, a price-to-earnings-growth ratio of 1.00 and a beta of 1.26. Cabot Co. has a 1 year low of $63.73 and a 1 year high of $103.49. The business’s 50 day moving average price is $96.71 and its 200 day moving average price is $86.29.

Cabot (NYSE:CBT) last posted its earnings results on Monday, May 6th. The specialty chemicals company reported $1.78 EPS for the quarter, topping analysts’ consensus estimates of $1.66 by $0.12. Cabot had a return on equity of 26.21% and a net margin of 11.51%. The company had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.04 billion. During the same period in the previous year, the business earned $1.33 earnings per share. The firm’s revenue for the quarter was down 1.4% on a year-over-year basis. Research analysts expect that Cabot Co. will post 6.78 EPS for the current fiscal year.

Cabot Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 14th. Shareholders of record on Friday, May 31st will be given a dividend of $0.43 per share. The ex-dividend date is Friday, May 31st. This is an increase from Cabot’s previous quarterly dividend of $0.40. This represents a $1.72 dividend on an annualized basis and a yield of 1.75%. Cabot’s dividend payout ratio is 21.77%.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.